Company / Total Assets
Apogee Therapeutics, Inc. Total Assets History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$754.0M
FY2024
5-year range
$152.1M / $754.0M
FY2022-FY2024
Trend
+87.8%
vs FY2023
Sector context
#101 of 214
Health Care
What the data says
At $754M, Apogee Therapeutics, Inc.'s total assets ranks #101 of 214 in the Health Care sector. Improved from $152M to $754M over the past 2 years.
Based on SEC 10-K filings.
$754M in FY2024.
Improved from $152M to $754M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#101 of 214 in Health CareTop 47% of 214This company $754.0M Sector average $7.5B
▼
-89.9% below sector average
Key checks
Key Insights
- In FY2024, total assets increased 87.8% year-over-year.
- Ranks #101 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $754.0M | +87.8% |
| FY2023 | $401.4M | +164.0% |
| FY2022 | $152.1M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026